<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Trofinetide</title><link>https://peptidescanner.com/peptides/trofinetide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Trofinetide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/trofinetide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT02715115</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02715115-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02715115-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct02715115-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-08-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04181723</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04181723-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04181723-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct04181723-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-04-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04279314</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04279314-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04279314-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#clinicaltrials-gov-nct04279314-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-04-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA217026</title><link>https://peptidescanner.com/stories/fda-drugs-nda217026/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda217026:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#fda-drugs-nda217026-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2023-03-10. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA219884</title><link>https://peptidescanner.com/stories/fda-drugs-nda219884/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda219884:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#fda-drugs-nda219884-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2025-12-11. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2023-06593</title><link>https://peptidescanner.com/stories/federal-register-2023-06593/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2023-06593:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#federal-register-2023-06593-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2023-03-30. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2024-21941</title><link>https://peptidescanner.com/stories/federal-register-2024-21941/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2024-21941:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#federal-register-2024-21941-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2024-09-25. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Trofinetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37279541-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37279541-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37279541-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-10-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37291210-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37291210-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37291210-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Trofinetide: a pioneering treatment for Rett syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37460385-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37460385-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-37460385-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-10-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Trofinetide-a new chapter in rett syndrome&apos;s treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38035006-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38035006-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38035006-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Development of trofinetide for the treatment of Rett syndrome: from bench to bedside.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38318312-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38318312-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38318312-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-10-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38378975-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38378975-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38378975-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Look at DAYBUE™ (Trofinetide) as first ever drug for treatment of Rett Syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38555801-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38555801-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38555801-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-05-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38869952-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38869952-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38869952-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-07-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Trofinetide (Daybue) for Rett syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38981105-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38981105-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-38981105-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-07-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Trofinetide treatment for Rett syndrome: Lessons to learn.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39395401-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39395401-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39395401-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-06-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39692837-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39692837-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39692837-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Assessing Experiences With Trofinetide for Rett Syndrome: Interviews With Caregivers of Participants in Clinical Trials.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39824747-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39824747-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-39824747-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-05-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41850142-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41850142-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-41850142-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Hydrophobic Tag-Assisted Scalable Synthesis of Trofinetide and Its GPE Analogues.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42083929-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42083929-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42083929-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rett syndrome and real-world treatment patterns of trofinetide in the United States.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42287113-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42287113-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42287113-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-06-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42294489-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42294489-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42294489-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42377739-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42377739-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42377739-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi-Stage Computational Analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42530159-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42530159-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42530159-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Expert Consensus on Real-World Use of Trofinetide for Rett Syndrome Using a Modified Delphi Method.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42563928-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42563928-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42563928-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Characteristics of adult individuals with Rett syndrome treated or untreated with trofinetide in the United States.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42577214-trofinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42577214-trofinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/trofinetide.json#pubmed-pmid-42577214-trofinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
